Lexapro cipralex escitalopram regulatory update

Mochida submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for escitalopram to treat depression. Mochida has Japanese development and commercialization rights to escitalopram from Lundbeck. Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508, Osaka, Japan) has co-marketing rights in Japan to the allosteric serotonin reuptake inhibitor (SSRI). ...